Technical Field
The present invention relates to an antiseptic cap and an antiseptic cap equipped syringe plunger assembly and more particularly to an antiseptic cap for attaching to a portion of an indwelling, central venous catheter and delivering an antiseptic composition or liquid to a lumen of the catheter.
Background Art
Catheters are widely used to treat patients requiring a variety of medical procedures. Catheters can either be acute, or temporary, for short-term use or chronic for long-term treatment. Catheters are commonly inserted into central veins (such as the vena cava) from peripheral vein sites to provide access to a patient's vascular system. Catheters offer many advantages for patients; for example, chronic catheters provide ready access without repeated punctures or repeated vessel cannulation for administration of large volumes of fluids, nutrients and medications and for withdrawal of blood on an intermittent basis. With respect to the use of catheters for infusion of fluids, examples include the infusion of drugs, electrolytes or fluids used in chemotherapy. In chemotherapy, catheters are used for infusion of drugs on an intermittent basis, ranging from daily to weekly. Another example includes the use of catheters in hyperalimentation treatment, wherein the catheters are usually used for infusion of large volumes of fluids.
For hemodialysis, catheters are commonly used—usually three times per week—for aspiration of blood for dialysis treatment and rapid return of the blood to circulation after treatment. Although a preferred mode of vascular access for a hemodialysis patient involves using an arteriovenous (AV) fistula of either the upper or lower extremities or an arteriovenous “bridge” graft (typically utilizing PTFE), use of these access devices is not always possible or desirable. When either of these modes of vascular access is not available, for example, due to a paucity of adequate blood vessels for creation of AV “shunts” or due to nonoptimally functioning established AV shunts, a large bore venous line catheter is typically required for hemodialysis. Catheters used for hemodialysis usually include two relatively large diameter lumens (usually molded as one catheter) for aspiration and rapid return of blood required during the hemodialysis procedure. One lumen of such a catheter is used for aspiration, or removal, of blood, while the other lumen is used for returning the blood to the patient's bloodstream.
Catheter connections, such as, for example, connections of catheters to dialysis machine tubing, to IV line tubing, to infusion ports and to catheter caps, which are used to seal the end of a catheter to protect the sterility of the catheter and prevent fluid loss and/or particle contamination, are most often made utilizing the medical industry's standardized Luer taper fittings. These fittings, which may either be male couplings or female couplings, include a tapered end of standardized dimensions. Coupling is made by the press-fit of mating parts. A threaded lock-fit or other type of securing mechanism is commonly utilized to ensure the integrity of the pressure fit of the Luer fittings.
Catheters, especially chronic venous catheters, provide challenges in their use. One such challenge is that such catheters can become occluded by a thrombus. In order to prevent clotting of catheters in blood vessels between uses, such as, for example, between dialysis treatments when the catheter is essentially nonfunctioning and dwells inside a “central” vein (i.e. superior vena cava, inferior vena cava, iliac, etc.), the lumens of the catheter are often filled with a lock solution of a concentrated solution of the commonly used anticoagulant, heparin (up to 10,000 units of heparin per catheter lumen).
As used herein, the terms “lock solution” or “locking solution” refer to a solution that is injected or otherwise infused into a lumen of a catheter with the intention of allowing a substantial portion of the lock solution to remain in the lumen and not in the systemic blood circulation until it is desired or required to access that particular lumen again, typically for additional treatment, i.e., infusion or withdrawal of fluid. In addition, attention has been given to the development of alternative lock solutions with the goal of improving the patency rates of vascular catheters. For example, lower-alcohol containing locking solutions are under development wherein the lower alcohols include ethanol, propanol and butanol. Anti-microbial and or anticoagulant additives can optionally be added to the lower-alcohol containing locking solution. Preferably the lock solution can remain in the lumen for a desired amount of time lasting from about 1 hour to 3 or 4 days or longer.
For the reasons set forth above, significant care must be taken when infusing medications, nutrients and the like into a catheter, and when “locking” a catheter between uses, to minimize the risks associated with an indwelling catheter, including the risk of thrombosis or clotting, the risk of excessive anticoagulating and the risk of infection. Syringes are typically used to administer the required amount of catheter lock solution (determined by the catheter manufacturer) into an indwelling catheter after a given use. Flush procedures also require that care be taken to prevent blood reflux into the catheter. Reflux in I.V. therapy is the term commonly used to describe the fluid that is drawn back into the catheter after a flush procedure. The concern is that the reflux fluid contains blood or solution that could cause the catheter to occlude. To ensure that reflux does not occur, flush procedures suggest two techniques: 1) at the end of the flush solution delivery, the user maintains pressure on the syringe plunger while clamping the I.V. line; or 2) while delivering the last 0.5 ml of flush solution disconnect the syringe from the I.V. port or clamp the I.V. line. Either technique maintains positive pressure on the fluid in the catheter to prevent reflux of fluid and blood.
Another concern in catheter care is the prevention of infections. Once source of infections can be through germs that enter the blood stream from the open end of the catheter. Various techniques are known in the art of blocking the exit of the catheter to prevent the refluxing of blood up the catheter and to close the system off from general atmosphere. Certain closures are straight-forward screw-caps that fit over the luer end of the catheter. Others are complex valving systems that may reduce reflux during detachment of the syringes or other connections. Others are pre-slit septums that seal together when the syringe or connected device is removed.
Current procedures to reduce contamination of a catheter, during connection and disconnection, is to swab the connection hub with a disinfectant such as an alcohol. This procedure is prone to human error such as failing to allow sufficient between swabbing and closing of the catheter. Further, sometimes the swabbing step is skipped all together.
In light of the above-described problems, there is a continuing need for advancements in catheter lock techniques, devices and procedures to improve the safety and efficacy of catheter locking procedures, the cleanliness and disinfection of catheter connections and of overall patient care.
a,b are, respectively, side views in cutaway showing an antiseptic cap with a centrally disposed actuation post mounted on a valve with the valve in the unactivated and activated positions;
While this invention is susceptible of embodiment in many different forms, there are shown in the drawings, and will be described herein in detail, specific embodiments thereof with the understanding that the present disclosure is to be considered as an exemplification of the principles of the invention and is not intended to limit the invention to the specific embodiments illustrated.
In one preferred form of the invention the chamber 18 of the syringe assembly will be filled with a locking solution or a flush solution for use with an indwelling, central venous catheter. The manner of using a locking or flush solution with a catheter is well known in the art. Suitable locking or flushing solutions will be set forth below. The flush or locking solution is injected into a fluid access site of the catheter to clean and disinfect the catheter and can be withdrawn from the catheter or allowed to remain in an end portion of the catheter to serve as a barrier to the ingress of pathogens and contaminants.
The antiseptic cap plunger assembly 12 has an elongate shaft 40, a proximal end 42 and a distal end 44. The elongate shaft 40, in one preferred form of the invention, is generally cruciform in cross-sectional shape. A stopper or piston 50 is connected to the distal end 44 of the plunger 12. The piston 50 is dimensioned such that when inserted into the syringe barrel chamber 18 an outer circumferential surface of the piston is in fluid-tight engagement with an inner surface 54 of the syringe barrel. The piston assembly 12 when moved proximally (or when being withdrawn) can draw fluid into the chamber and when moved distally (or when inserted into the syringe chamber) can drive fluid out of the chamber.
A housing 60 is located at the proximal end of the plunger assembly 12 and has a wall 62 defining a chamber 64 having an open end 66 which can be sealed by any suitable structure or material such as a cap or by a foil material 68. An optional annular flange 70 extends radially outwardly from the wall 62 and provides a surface upon which the sealing structure can be attached.
It is desirable that during the rotation of the syringe barrel that the antiseptic cap assembly 80 does not rotate with respect to the housing and/or optionally that the plunger assembly 12 does not rotate with respect to the syringe barrel 14 so that the threads 88 of the antiseptic cap can, fully engage the threads of the access site. The present invention provides a mechanism associated with the assembly 10 for preventing the rotation of the antiseptic cap assembly 80 with respect to the plunger assembly 12 and more preferably a mechanism on either the plunger assembly or on the antiseptic cap 80 to prevent relative rotational movement between the antiseptic cap 80 and the plunger assembly 12. In an even more preferred form of the invention, the mechanism for preventing relative rotation of the antiseptic cap 80 with respect to the plunger assembly 12 has mating portions on both parts that when assembled cooperatively engage one another to prevent relative rotation. It is also contemplated that a separate mechanism, device or member could be used to lock the two parts together to achieve this purpose.
If a user of the assembly 10 grasps the assembly 10 by the antiseptic cap and plunger assembly 12, then the interlocking structures between the piston assembly 12 and the syringe barrel 14 would not necessarily be needed. Accordingly,
In one preferred form of the invention the housing 60 will have a feature or structure that forms an interference fit with an external surface of the antiseptic cap 80. Even more preferably, the internal surface of the side wall 62 of the housing will have a feature or structure to form an interference fit with a portion of the antiseptic cap 80. In another preferred form of the invention the antiseptic cap will have a feature to form an interference fit with the housing 60 and even more preferably the outer surface of the antiseptic cap 80 will have a feature to contact the inner surface of the housing side wall 62.
In another preferred form of the invention the housing and the cap each have a feature or structure that cooperatively engage one another to prevent relative rotation of the cap 80 and the housing 60.
The antiseptic cap 82 has a plurality of circumferentially spaced and axially extending ribs 120 extending along an external surface 122 of the cap 82 (external ribs 120) from an annular flange 123. The external ribs 120 are dimensioned for engaging a portion of the interior wall of the housing 62 to prevent relative rotation of the cap and the plunger assembly 12 and define a plurality of external slots one of each between each adjacent pair of external ribs. When the cap 82 is positioned within the chamber 64 (
As with the cap and plunger assembly rotational locking features or structures, the optional plunger assembly and syringe barrel locking feature or structure can be positioned alone on the plunger assembly 12, or alone on the syringe barrel or have cooperating structures on both the plunger assembly 12 and the syringe barrel. It is also contemplated that a separate mechanism, device or member could be used to lock the two parts together to achieve this purpose.
It is contemplated that the antiseptic cap 80 of the present invention need not be coupled or combined with a plunger or a piston.
Suitable sponges of the present invention can include any sponge suitable for use for medical purposes and can be naturally occurring or synthetic. The sponges can be die cut into suitable shapes or can be molded into the desired shape. It is desirable that the sponge 86 be attached to the antiseptic cap to prevent the sponge from inadvertently falling out of the cap.
When the cap is not incorporated into the plunger assembly, many packaging options exist. One such embodiment,
The syringe barrel and plunger can be fabricated from any material suitable for its purpose and includes glass and polymeric material. Suitable polymeric materials include, but are not limited to, homopolymers, copolymers and terpolymers formed from monomers such as olefins, cyclic olefins, amides, esters, and ethers. The polymeric material may be a blend of more than one polymeric material and can be a monolayer structure or a multilayer structure. In one preferred form of the invention the syringe barrel and the plunger are injection molded from a polypropylene material.
The piston 50 can be formed from any suitable material including a polymeric material, natural or synthetic rubber or a silicone material. The stopper can be selected from a material with a desired durometer so that reflux is reduced when the stopper engages an inner surface of the distal end wall of the syringe barrel.
Suitable locking and flush solutions for filling inside the syringe barrel and/or for soaking the sponge 86 include a lower alcohol selected from ethanol, propanol and butanol. The locking solution can be a single lower alcohol or a blend of lower alcohols.
Suitable locking solutions can also include a lower alcohol with an antimicrobial and or an anticoagulant. Thus, the locking solution can have a single component, two components or more than two components. Suitable locking solutions can contain at least one lower alcohol in a range from 1% to 99% by volume and at least one other anti-microbial and/or anti-coagulant compound in a range from 1% to 99% by volume. The lower alcohol will usually be in aqueous solution, typically at 1% to 99% by volume, usually from 5% to 95% by volume. The at least one other anti-microbial is selected from the group consisting of taurolidine and triclosan, and the at least one anti-coagulant is selected from the group consisting of riboflavin, sodium citrate, ethylene diamine tetraacetic acid, and citric acid.
In one preferred form of the invention, the syringe assembly 10 will be pre-filled with one of the locking solutions and will be packaged by a manufacture and shipped to a health care provider. A cannula or needle will be attached to the distal end of the barrel and placed into fluid communication with the fluid access site of an indwelling central venous catheter. The flush solution will be injected into the catheter to clean or lock the catheter. Afterwards, the cap assembly 80 will be removed from the plunger 17 and the cap will be docked to the fluid access site of the catheter.
From the foregoing, it will be observed that numerous variations and modifications may be effected without departing from the spirit and scope of the invention. It is to be understood that no limitation with respect to the specific apparatus illustrated herein is intended or should be inferred. It is, of course, intended to cover by the appended claims all such modifications as fall within the scope of the claims.
This application is a continuation of U.S. patent application Ser. No. 13/456,853 filed on Apr. 26, 2012, which is a continuation of U.S. patent application Ser. No. 11/821,190 filed on Jun. 22, 2007, now U.S. Pat. No. 8,167,847, which claims the benefit of U.S. Provisional Application No. 60/815,806 filed on Jun. 22, 2006, the entire disclosures of which are all expressly incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
877946 | Overton | Feb 1908 | A |
1793068 | Dickinson | Feb 1931 | A |
2098340 | Henahan | Nov 1937 | A |
2436297 | Guarnaschelli | Feb 1948 | A |
3270743 | Gingras | Sep 1966 | A |
3301392 | Eddingfield | Jan 1967 | A |
3882858 | Klemm | May 1975 | A |
3977401 | Pike | Aug 1976 | A |
3987930 | Fuson | Oct 1976 | A |
4041934 | Genese | Aug 1977 | A |
4095810 | Kulle | Jun 1978 | A |
4243035 | Barrett | Jan 1981 | A |
4280632 | Yuhara | Jul 1981 | A |
4294370 | Toeppen | Oct 1981 | A |
4317446 | Ambrosio et al. | Mar 1982 | A |
4335756 | Sharp et al. | Jun 1982 | A |
4384589 | Morris | May 1983 | A |
4402691 | Rosenthal et al. | Sep 1983 | A |
4417890 | Dennehey et al. | Nov 1983 | A |
4427126 | Ostrowsky | Jan 1984 | A |
4432764 | Lopez | Feb 1984 | A |
4432766 | Bellotti et al. | Feb 1984 | A |
4439184 | Wheeler | Mar 1984 | A |
4440207 | Genatempo et al. | Apr 1984 | A |
4444310 | Odell | Apr 1984 | A |
4461368 | Plourde | Jul 1984 | A |
4480940 | Woodruff | Nov 1984 | A |
4507111 | Gordon et al. | Mar 1985 | A |
4624664 | Peluso et al. | Nov 1986 | A |
4666057 | Come et al. | May 1987 | A |
4666427 | Larsson et al. | May 1987 | A |
4671306 | Spector | Jun 1987 | A |
4703762 | Rathbone et al. | Nov 1987 | A |
4728321 | Chen | Mar 1988 | A |
4747502 | Luenser | May 1988 | A |
4752983 | Grieshaber | Jun 1988 | A |
4778447 | Velde et al. | Oct 1988 | A |
4799926 | Haber | Jan 1989 | A |
4811847 | Reif et al. | Mar 1989 | A |
4813933 | Turner | Mar 1989 | A |
4927019 | Haber et al. | May 1990 | A |
4957637 | Cornell | Sep 1990 | A |
4983161 | Dadson et al. | Jan 1991 | A |
4989733 | Patry | Feb 1991 | A |
4991629 | Ernesto et al. | Feb 1991 | A |
5143104 | Iba et al. | Sep 1992 | A |
5190534 | Kendell | Mar 1993 | A |
5205821 | Kruger et al. | Apr 1993 | A |
5242421 | Chan | Sep 1993 | A |
5242425 | White et al. | Sep 1993 | A |
5246011 | Caillouette | Sep 1993 | A |
D342134 | Mongeon | Dec 1993 | S |
5352410 | Hansen et al. | Oct 1994 | A |
5471706 | Wallock et al. | Dec 1995 | A |
5536258 | Folden | Jul 1996 | A |
5552115 | Malchesky | Sep 1996 | A |
5554135 | Menyhay | Sep 1996 | A |
5580530 | Kowatsch et al. | Dec 1996 | A |
5620088 | Martin et al. | Apr 1997 | A |
5624402 | Imbert | Apr 1997 | A |
5694978 | Heilmann et al. | Dec 1997 | A |
5702017 | Goncalves | Dec 1997 | A |
5722537 | Sigler | Mar 1998 | A |
5792120 | Menyhay | Aug 1998 | A |
5810792 | Fangrow, Jr. et al. | Sep 1998 | A |
5820604 | Fox et al. | Oct 1998 | A |
5827244 | Boettger | Oct 1998 | A |
5941857 | Nguyen et al. | Aug 1999 | A |
5954957 | Chin-Loy et al. | Sep 1999 | A |
5971972 | Rosenbaum | Oct 1999 | A |
D416086 | Parris et al. | Nov 1999 | S |
5989229 | Chiappetta | Nov 1999 | A |
6045539 | Menyhay | Apr 2000 | A |
6116468 | Nilson | Sep 2000 | A |
6117114 | Paradis | Sep 2000 | A |
6126640 | Tucker et al. | Oct 2000 | A |
6179141 | Nakamura | Jan 2001 | B1 |
6202870 | Pearce | Mar 2001 | B1 |
6206134 | Stark et al. | Mar 2001 | B1 |
6227391 | King | May 2001 | B1 |
6250315 | Ernster | Jun 2001 | B1 |
6315761 | Shcherbina et al. | Nov 2001 | B1 |
6394983 | Mayoral et al. | May 2002 | B1 |
6550493 | Williamson et al. | Apr 2003 | B2 |
6555504 | Ayai et al. | Apr 2003 | B1 |
6585691 | Vitello | Jul 2003 | B1 |
6679395 | Pfefferkorn et al. | Jan 2004 | B1 |
6679870 | Finch et al. | Jan 2004 | B1 |
6685694 | Finch et al. | Feb 2004 | B2 |
6716396 | Anderson | Apr 2004 | B1 |
6827766 | Carnes et al. | Dec 2004 | B2 |
6911025 | Miyahara | Jun 2005 | B2 |
6943035 | Davies et al. | Sep 2005 | B1 |
7056308 | Utterberg | Jun 2006 | B2 |
7083605 | Miyahara | Aug 2006 | B2 |
7198611 | Connell et al. | Apr 2007 | B2 |
7282186 | Lake, Jr. et al. | Oct 2007 | B2 |
7431712 | Kim | Oct 2008 | B2 |
7452349 | Miyahara | Nov 2008 | B2 |
7516846 | Hansen | Apr 2009 | B2 |
7635344 | Tennican et al. | Dec 2009 | B2 |
D607325 | Rogers et al. | Jan 2010 | S |
7731678 | Tennican et al. | Jun 2010 | B2 |
7731679 | Tennican et al. | Jun 2010 | B2 |
7749189 | Tennican et al. | Jul 2010 | B2 |
7753891 | Tennican et al. | Jul 2010 | B2 |
7763006 | Tennican | Jul 2010 | B2 |
7766182 | Trent et al. | Aug 2010 | B2 |
7776011 | Tennican et al. | Aug 2010 | B2 |
7780794 | Rogers et al. | Aug 2010 | B2 |
7794675 | Lynn | Sep 2010 | B2 |
7799010 | Tennican | Sep 2010 | B2 |
7857793 | Raulerson et al. | Dec 2010 | B2 |
7922701 | Buchman | Apr 2011 | B2 |
7959026 | Bertani | Jun 2011 | B2 |
7985302 | Rogers et al. | Jul 2011 | B2 |
7993309 | Schweikert | Aug 2011 | B2 |
8065773 | Vaillancourt et al. | Nov 2011 | B2 |
8069523 | Vaillancourt et al. | Dec 2011 | B2 |
8162899 | Tennican | Apr 2012 | B2 |
8167847 | Anderson et al. | May 2012 | B2 |
8206514 | Rogers et al. | Jun 2012 | B2 |
8231587 | Solomon et al. | Jul 2012 | B2 |
8231602 | Anderson et al. | Jul 2012 | B2 |
8273303 | Ferlic et al. | Sep 2012 | B2 |
8343112 | Solomon et al. | Jan 2013 | B2 |
8361408 | Lynn | Jan 2013 | B2 |
8372045 | Needle et al. | Feb 2013 | B2 |
8480968 | Lynn | Jul 2013 | B2 |
8523831 | Solomon et al. | Sep 2013 | B2 |
8545479 | Kitani et al. | Oct 2013 | B2 |
8647326 | Solomon et al. | Feb 2014 | B2 |
8740864 | Hoang et al. | Jun 2014 | B2 |
8777504 | Shaw et al. | Jul 2014 | B2 |
9114915 | Solomon et al. | Aug 2015 | B2 |
9192449 | Kerr et al. | Nov 2015 | B2 |
9259535 | Anderson et al. | Feb 2016 | B2 |
9283367 | Hoang et al. | Mar 2016 | B2 |
9283368 | Hoang et al. | Mar 2016 | B2 |
9289588 | Chen | Mar 2016 | B2 |
9302049 | Tekeste | Apr 2016 | B2 |
9352140 | Kerr et al. | May 2016 | B2 |
9352141 | Wong | May 2016 | B2 |
9399125 | Burkholz | Jul 2016 | B2 |
9408971 | Carlyon | Aug 2016 | B2 |
20020193752 | Lynn | Dec 2002 | A1 |
20030153865 | Connell et al. | Aug 2003 | A1 |
20040034042 | Tsuji et al. | Feb 2004 | A1 |
20040048542 | Thomascheisky et al. | Mar 2004 | A1 |
20040215148 | Hwang et al. | Oct 2004 | A1 |
20040258560 | Lake, Jr. et al. | Dec 2004 | A1 |
20050013836 | Raad | Jan 2005 | A1 |
20050065479 | Schiller et al. | Mar 2005 | A1 |
20050124970 | Kunin et al. | Jun 2005 | A1 |
20050147524 | Bousquet | Jul 2005 | A1 |
20050148930 | Hsieh et al. | Jul 2005 | A1 |
20050203460 | Kim | Sep 2005 | A1 |
20050214185 | Castaneda | Sep 2005 | A1 |
20060030827 | Raulerson et al. | Feb 2006 | A1 |
20070112333 | Hoang et al. | May 2007 | A1 |
20070167910 | Tennican et al. | Jul 2007 | A1 |
20070187353 | Fox et al. | Aug 2007 | A1 |
20070249996 | Tennican et al. | Oct 2007 | A1 |
20070265578 | Tennican et al. | Nov 2007 | A1 |
20070282280 | Tennican | Dec 2007 | A1 |
20070287989 | Crawford et al. | Dec 2007 | A1 |
20080019889 | Rogers et al. | Jan 2008 | A1 |
20080027399 | Harding et al. | Jan 2008 | A1 |
20080033371 | Updegraff et al. | Feb 2008 | A1 |
20080039803 | Lynn | Feb 2008 | A1 |
20080058733 | Vogt et al. | Mar 2008 | A1 |
20080086091 | Anderson et al. | Apr 2008 | A1 |
20080093245 | Periasamy et al. | Apr 2008 | A1 |
20080095680 | Steffens et al. | Apr 2008 | A1 |
20080132880 | Buchman | Jun 2008 | A1 |
20080147047 | Davis et al. | Jun 2008 | A1 |
20080177250 | Howlett et al. | Jul 2008 | A1 |
20080235888 | Vaillancourt et al. | Oct 2008 | A1 |
20090008393 | Howlett et al. | Jan 2009 | A1 |
20090012426 | Tennican | Jan 2009 | A1 |
20090062766 | Howlett et al. | Mar 2009 | A1 |
20090093757 | Tennican | Apr 2009 | A1 |
20090099529 | Anderson et al. | Apr 2009 | A1 |
20090137969 | Colantonio et al. | May 2009 | A1 |
20090205151 | Fisher et al. | Aug 2009 | A1 |
20090205656 | Nishibayashi et al. | Aug 2009 | A1 |
20090259194 | Pinedjian et al. | Oct 2009 | A1 |
20100003067 | Shaw et al. | Jan 2010 | A1 |
20100047123 | Solomon et al. | Feb 2010 | A1 |
20100049170 | Solomon et al. | Feb 2010 | A1 |
20100064456 | Ferlic | Mar 2010 | A1 |
20100160894 | Julian et al. | Jun 2010 | A1 |
20100172794 | Ferlic et al. | Jul 2010 | A1 |
20100242993 | Hoang et al. | Sep 2010 | A1 |
20100306938 | Rogers et al. | Dec 2010 | A1 |
20110030726 | Vaillancourt et al. | Feb 2011 | A1 |
20110044850 | Solomon et al. | Feb 2011 | A1 |
20110232020 | Rogers et al. | Sep 2011 | A1 |
20110265825 | Rogers et al. | Nov 2011 | A1 |
20110277788 | Rogers et al. | Nov 2011 | A1 |
20110290799 | Anderson et al. | Dec 2011 | A1 |
20120109073 | Anderson et al. | May 2012 | A1 |
20120195807 | Ferlic | Aug 2012 | A1 |
20120216359 | Rogers et al. | Aug 2012 | A1 |
20120216360 | Rogers et al. | Aug 2012 | A1 |
20120283693 | Anderson et al. | Nov 2012 | A1 |
20120296284 | Anderson et al. | Nov 2012 | A1 |
20120302970 | Tennican | Nov 2012 | A1 |
20120302997 | Gardner et al. | Nov 2012 | A1 |
20130035667 | Anderson et al. | Feb 2013 | A1 |
20140101876 | Rogers et al. | Apr 2014 | A1 |
20150018774 | Anderson et al. | Jan 2015 | A1 |
20150217106 | Banik et al. | Aug 2015 | A1 |
20150314119 | Anderson et al. | Nov 2015 | A1 |
20150314120 | Gardner et al. | Nov 2015 | A1 |
20150374968 | Solomon et al. | Dec 2015 | A1 |
20160045629 | Gardner et al. | Feb 2016 | A1 |
20160067471 | Ingram et al. | Mar 2016 | A1 |
20160088995 | Ueda et al. | Mar 2016 | A1 |
20160089530 | Sathe | Mar 2016 | A1 |
20160101276 | Tekeste | Apr 2016 | A1 |
20160106969 | Neftel | Apr 2016 | A1 |
20160121097 | Steele | May 2016 | A1 |
20160144118 | Solomon et al. | May 2016 | A1 |
20160158521 | Hoang et al. | Jun 2016 | A1 |
20160158522 | Hoang et al. | Jun 2016 | A1 |
20160213912 | Daneluzzi | Jul 2016 | A1 |
20160250420 | Maritan et al. | Sep 2016 | A1 |
Number | Date | Country |
---|---|---|
2148847 | Dec 1995 | CA |
2169689 | Aug 1996 | CA |
2583601 | Apr 2006 | CA |
2626864 | May 2007 | CA |
2651192 | Nov 2007 | CA |
2615146 | Jun 2008 | CA |
2402327 | Oct 2000 | CN |
2815392 | Sep 2006 | CN |
201150420 | Nov 2008 | CN |
29617133 | Jan 1997 | DE |
0108785 | May 1984 | EP |
0227219 | Jul 1987 | EP |
0245872 | Nov 1987 | EP |
0769265 | Apr 1997 | EP |
1061000 | Dec 2000 | EP |
1331020 | Jul 2003 | EP |
1977714 | Oct 2008 | EP |
2493149 | May 1982 | FR |
2782910 | Mar 2000 | FR |
123221 | Feb 1919 | GB |
2296182 | Jun 1996 | GB |
2333097 | Jul 1999 | GB |
2387772 | Oct 2003 | GB |
H04-99950 | Mar 1992 | JP |
2002-291906 | Oct 2002 | JP |
2006-182663 | Jul 2006 | JP |
2246321 | Feb 2005 | RU |
WO 8303975 | Nov 1983 | WO |
WO 9812125 | Mar 1998 | WO |
WO 2004035129 | Apr 2004 | WO |
WO 2004112846 | Dec 2004 | WO |
WO 2006007690 | Jan 2006 | WO |
WO 2006044236 | Apr 2006 | WO |
WO 2007056773 | May 2007 | WO |
WO 2007137056 | Nov 2007 | WO |
WO 2008086631 | Jul 2008 | WO |
WO 2008089196 | Jul 2008 | WO |
WO 2008100950 | Aug 2008 | WO |
WO 2008140807 | Nov 2008 | WO |
WO 2009002474 | Dec 2008 | WO |
WO 2009117135 | Sep 2009 | WO |
WO 2009123709 | Oct 2009 | WO |
WO 2009136957 | Nov 2009 | WO |
WO 2009153224 | Dec 2009 | WO |
WO 2010002757 | Jan 2010 | WO |
WO 2010002808 | Jan 2010 | WO |
WO 2010039171 | Apr 2010 | WO |
WO 2011028722 | Mar 2011 | WO |
WO 2011119021 | Sep 2011 | WO |
Entry |
---|
Examination Report dated Jun. 6, 2011, issued by the Canadian Intellectual Property Office in connection with Canadian Patent Application No. 2,692,157 (2 pages). |
Examination Report dated Apr. 27, 2011, issued by the Canadian Intellectual Property Office in connection with Canadian Patent Application No. 2,692,157 (3 pages). |
Examination Report dated Jan. 23, 2013, issued by the Canadian Intellectual Property Office in connection with Canadian Patent Application No. 2,692,157 (4 pages). |
Notice of Allowance dated Oct. 2, 2013, issued by the Canadian Intellectual Property Office in connection with Canadian Patent Application No. 2,692,157 (1 page). |
Office Action dated Oct. 2012, issued by the Intellectual Property Office of Colombia in connection with Colombian Patent Application No. 10.000.937 (9 pages). |
Examination Report dated Jun. 13, 2011, issued by the Intellectual Property Office of New Zealand in connection with New Zealand Patent Application No. 582395 (2 pages). |
Examination Report and Notice of Acceptance of Complete Specification dated Dec. 5, 2012, issued by the Intellectual Property Office of New Zealand in connection with New Zealand Patent Application No. 582395 (1 page). |
Interview Summary dated Nov. 18, 2010, from pending U.S. Appl. No. 11/821,190 (4 pages). |
Notice of Allowance dated Jul. 29, 2011, from U.S. Appl. No. 11/821,190 (6 pages). |
Notification of First Office Action dated Aug. 3, 2011, issued by the State Intellectual Property Office of the People's Republic of China in connection with Chinese Patent Application No. 200880103854.5 (5 pages). |
International Search Report of the International Searching Authority mailed Sep. 11, 2008, issued in connection with International Patent Application No. PCT/US08/07797 (2 pages). |
Written Opinion of the International Searching Authority mailed Sep. 11, 2008, issued in connection with International Patent Appln. No. PCT/US08/07797 (3 pages). |
Office Action dated Jun. 9, 2011 from U.S. Appl. No. 12/214,526 (7 pages). |
Final Office Action dated Oct. 31, 2011 from U.S. Appl. No. 12/214,526 (8 pages). |
Interview Summary dated Mar. 23, 2012 from U.S. Appl. No. 12/214,526 (3 pages). |
Redacted version of letter from David A. Divine, Esq. of Lee & Hayes, dated May 27, 2011 (3 pages). |
Redacted version of letter from David A. Divine, Esq. of Lee & Hayes, dated May 16, 2011 (3 pages). |
Photographs of the Baxter Minicap (Sep. 1, 1998) (4 pages). |
Office Action dated Dec. 21, 2011 from U.S. Appl. No. 13/095,516 (27 pages). |
Office Action dated Dec. 17, 2009 from U.S. Appl. No. 11/821,190 (10 pages). |
Office Action dated Aug. 2, 2010 from U.S. Appl. No. 11/821,190 (14 pages). |
Office Action dated Mar. 7, 2011 from U.S. Appl. No. 11/821,190 (16 pages). |
Notice of Allowance dated Apr. 26, 2011 from U.S. Appl. No. 11/821,190 (9 pages). |
Second Office Action dated Apr. 16, 2012, along with English translation, issued by the State Intellectual Property Office of the People's Republic of China in connection with Chinese Patent Application No. 200880103854.5 (4 pages). |
Third Office Action dated Nov. 1, 2012, along with English translation, issued by the State Intellectual Property Office of the People's Republic of China in connection with Chinese Patent Application No. 200880103854.5 (4 pages). |
Non-final office action dated Dec. 3, 2013 from U.S. Appl. No. 13/113,777 (13 pages). |
Notice of Allowance dated May 16, 2012 from U.S. Appl. No. 13/095,516 (18 pages). |
Non-final Office Action dated Feb. 8, 2013 from U.S. Appl. No. 13/473,057 (20 pages). |
Final Office Action dated Dec. 3, 2013 from U.S. Appl. No. 13/473,057 (19 pages). |
Examination Report No. 3 dated May 1, 2013, issued by the Intellectual Property Office of Australia in connection with Australian Patent Application No. 2008269133 (3 pages). |
Preliminary Report on Patentability dated Dec. 22, 2009, in connection with International Patent Application No. PCT/US08/07797 (4 pages). |
Non-final Office Action dated Dec. 14, 2012 from U.S. Appl. No. 13/456,853 (16 pages). |
Final Office Action dated Aug. 27, 2013 from U.S. Appl. No. 13/456,853 (18 pages). |
International Search Report of the International Searching Authority mailed Oct. 26, 2012, issued in connection with International Patent Application No. PCT/US2012/037772 (5 pages). |
Written Opinion of the International Searching Authority dated Oct. 26, 2012, issued in connection with International Patent Appin. No. PCT/US2012/037772 (7 pages). |
International Preliminary Report on Patentability dated Nov. 26, 2013, issued in connection with International Patent Application No. PCT/US2012/037772 (1 page). |
International Search Report of the International Searching Authority dated Nov. 19, 2012, issued in connection with International Patent Application No. PCT/US2012/038880 (5 pages). |
Written Opinion of the International Searching Authority dated Nov. 19, 2012, issued in connection with International Patent Appln. No. PCT/US2012/038880 (8 pages). |
International Preliminary Report on Patentability dated Nov. 20, 2013, issued in connection with International Patent Application No. PCT/US2012/038880 (1 page). |
Memo concerning Official Action dated Feb. 25, 2013, issued in connection with Mexican Application No. MX/a/2010/000171 (2 pages). |
Second Memo concerning Official Action mailed Oct. 22, 2013, issued in connection with Mexican Application No. MX/a/2010/000171 (1 page). |
Examination Report dated Nov. 8, 2012, issued by the Intellectual Property Office of New Zealand in connection with New Zealand Patent Application No. 603404 (2 pages). |
Examination Report dated Apr. 18, 2013, issued by the Intellectual Property Office of Australia in connection with Australian Patent Application No. 2012258435 (4 pages). |
Innovation Patent Examination Report No. 1 dated Apr. 18, 2013, issued by the Intellectual Property Office of Australia in connection with Australian Patent Application No. 2013100345 (3 pages). |
Menyhay, et al., “Disinfection of Needleless Catheter Connectors and Access Ports with Alcohol May Not Prevent Microbial Entry: The Promise of a Novel Antiseptic-Barrier Cap” Infection Control Hospital and Epidemiology, vol. 27, No. 1 (Jan. 2006) (5 pages). |
Copy of International Standard, “Conical fittings with 6% (Luer) Taper for Syringes, Needles and Certain Other Medical Equipment- Part 2: Lock Fittings” Ref. No. ISO 594-2: 1998. International Organization for Standardization (Sep. 1, 1998) 2nd ed. (16 pages). |
Notice of Acceptance dated Nov. 14, 2013, issued by the Intellectual Property Office of Australia in connection with Australian Patent Application No. 2008269133 (2 pages). |
Examination Report dated Nov. 8, 2012, issued by the Intellectual Property Office of New Zealand in connection with New Zealand Patent Application No. 582395 (2 pages). |
Examinantion Report No. 1 dated Aug. 27, 2012, issued by the Intellectual Property Office of Australia in connection with Australian Patent Application No. 2008269133 (4 pages). |
Examination Report No. 2 dated Jan. 9, 2013, issued by the Intellectual Property Office of Australia in connection with Australian Patent Application No. 2008269133 (3 pages). |
Office Action dated Mar. 27, 2014 from U.S. Appl. No. 13/456,853 (13 pages). |
International Search Report of the International Searching Authority mailed Feb. 14, 2013, issued in connection with International Patent Application No. PCT/US2012/062078 (3 pages). |
Written Opinion of the International Searching Authority mailed Feb. 14, 2013, issued in connection with International Patent Appln. No. PCT/US2012/062078 (3 pages). |
International Preliminary Report on Patentability mailed May 6, 2014, issued in connection with International Patent Application No. PCT/US2012/062078 (4 pages). |
First Examination Report dated Apr. 8, 2014, issued by the Intellectual Property Office of New Zealand in connection with New Zealand Patent Application No. 623139 (1 page). |
First Examination Report dated Apr. 9, 2014, issued by the Intellectual Property Office of New Zealand in connection with New Zealand Patent Application No. 623141 (1 page). |
First Office Action dated May 4, 2014, along with English translation, issued by the State Intellectual Property Office of the People's Republic of China in connection with Chinese Patent Application No. 201310087320.0 (20 pages). |
International Search Report of the International Searching Authority mailed Jul. 28, 2014, issued in connection with International Patent Application No. PCT/US2014/23140 (3 pages). |
Written Opinion of the International Searching Authority mailed Jul. 28, 2014, issued in connection with International Patent Appln. No. PCT/US2014/23140 (6 pages). |
Final Office Action dated Aug. 25, 2014 from U.S. Appl. No. 13/113,777 (9 pages). |
Notice of Allowance dated Dec. 3, 2014, from U.S. Appl. No. 13/456,853 (9 pages). |
First Examination Report dated Dec. 5, 2014, issued by the Intellectual Property Office of New Zealand in connection with New Zealand Patent Application No. 624449 (2 pages). |
Supplemental Expert Report of Charles Clemens, dated Aug. 15, 2014 (22 pages). |
Non-final Office Action dated Jan. 29, 2015 from U.S. Appl. No. 13/547,650 (9 pages). |
Office Action dated Nov. 21, 2014, issued by the Intellectual Property Office of Japan in connection with Japanese patent Application No. 2013-162527 (2 pages). |
Baxter Minicap: Photographs of the Baxter Minicap (Sep. 1, 1998) (4 pages). |
Baxter, “Peritoneal Dialysis Patient Connectology,” Product Descriptions in 1 page, downloaded Jul. 1, 2011 [Publication Date Unknown]. |
Catheter Connections, “Introducing DualCap,” Product Brochure in 1 page, Copyright 2011 [Publication Date unknown]. |
Hyprotek, “Port Protek,” Product Brochure in 1 page, downloaded Sep. 19, 2011 from http://www.hyprotek.com/products.html [Publication Date unknown]. |
Number | Date | Country | |
---|---|---|---|
20130035667 A1 | Feb 2013 | US |
Number | Date | Country | |
---|---|---|---|
60815806 | Jun 2006 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13456853 | Apr 2012 | US |
Child | 13649569 | US | |
Parent | 11821190 | Jun 2007 | US |
Child | 13456853 | US |